apollo

Select Address

Search Medicines
  • Login
  1. Home
  2. Nabcait 100 mg Injection 1's
  3. Nabcait 100 mg Injection 1's Substitute

Nabcait 100 mg Injection 1's Substitute

Substitutes safety advice
call Doctor

Verified Ingredients and Effects

Composition:

PACLITAXEL-100MG

Uses:

Treatment of Ovarian cancer, breast cancer, non-small cell lung cancer

Medicinal Benefits:

Nabcait 100 mg Injection 1's belongs to the group of anti-cancer medicines called anti-microtubule agents used to treat various types of cancers, including ovarian and breast cancer (in advanced/spreading state or after surgery) and advanced-stage non-small cell lung cancer. It may also be used when other treatments have failed or in combination with other treatments. Nabcait 100 mg Injection 1's may also be indicated in patients with Kaposi’s sarcoma (cancer that develops from the cells that line lymph or blood vessels) associated with AIDS (Acquired Immuno-Deficiency Syndrome), where other treatments have not been effective. Nabcait 100 mg Injection 1's contains ‘Paclitaxel’, which works by preventing the growth of certain cancer cells. 

FAQs

Nabcait 100 mg Injection 1's is used to treat Ovarian cancer, breast cancer, non-small cell lung cancer.

Nabcait 100 mg Injection 1's works by stopping cell division and preventing the growth of certain cancer cells.

Nabcait 100 mg Injection 1's might cause sterility which could be permanent. Please talk to your doctor if you have any concerns.

The most common side effect of Nabcait 100 mg Injection 1's is hair loss. The hair may grow back after the treatment with Nabcait 100 mg Injection 1's is finished. However, consult your doctor if you have any concerns.

Yes, Nabcait 100 mg Injection 1's is cytotoxic. It works by interfering with the growth of cancer cells, preventing them from dividing and causing them to die. However, its cytotoxic nature also means it can affect normal, healthy cells, potentially leading to side effects.

Yes, Nabcait 100 mg Injection 1's is considered a vesicant. A vesicant is a chemical substance that, if it leaks out of the vein (extravasation), can cause blistering of the skin and surrounding tissues. If Nabcait 100 mg Injection 1's accidentally leaks during intravenous (IV) infusion, it may lead to inflammation, blistering, or even tissue necrosis. Your healthcare provider will take precautions to ensure the drug is infused properly and monitor the infusion site for any signs of leakage. If extravasation occurs, the infusion should be stopped immediately, and steps should be taken to minimize the damage.

Nabcait 100 mg Injection 1's is an effective cancer treatment with a low risk of cardiac side effects. Your healthcare team will closely monitor your heart function to ensure your safety. They'll watch for any changes in heart rhythms or blood pressure, and work with you to manage any potential issues. With careful monitoring, you can receive this life-saving treatment with confidence.

Nabcait 100 mg Injection 1's is a natural product derived from the bark of the Pacific yew tree (Taxus baccata). It is a chemotherapy medication used to treat various cancers, including breast, ovarian, and lung cancer.

The common side effects of Nabcait 100 mg Injection 1's include nausea, vomiting, mild diarrhoea, and joint or muscle pain. Not everyone will experience all of these side effects, and they typically resolve once the treatment is stopped. However, if the side effects persist or worsen, please consult your doctor.